143 related articles for article (PubMed ID: 28173748)
1. Susceptibility to type 2 diabetes may be modulated by haplotypes in G6PC2, a target of positive selection.
Al-Daghri NM; Pontremoli C; Cagliani R; Forni D; Alokail MS; Al-Attas OS; Sabico S; Riva S; Clerici M; Sironi M
BMC Evol Biol; 2017 Feb; 17(1):43. PubMed ID: 28173748
[TBL] [Abstract][Full Text] [Related]
2. Meta-analyses of the association of G6PC2 allele variants with elevated fasting glucose and type 2 diabetes.
Shi Y; Li Y; Wang J; Wang C; Fan J; Zhao J; Yin L; Liu X; Zhang D; Li L
PLoS One; 2017; 12(7):e0181232. PubMed ID: 28704540
[TBL] [Abstract][Full Text] [Related]
3. Haplotypes of the genes (GCK and G6PC2) underlying the glucose/glucose-6-phosphate cycle are associated with pancreatic beta cell glucose sensitivity in patients with newly diagnosed type 2 diabetes from the VNDS study (VNDS 11).
Zusi C; Rinaldi E; Bonetti S; Boselli ML; Trabetti E; Malerba G; Bonora E; Bonadonna RC; Trombetta M
J Endocrinol Invest; 2021 Dec; 44(12):2567-2574. PubMed ID: 34128214
[TBL] [Abstract][Full Text] [Related]
4. Identification and functional characterization of G6PC2 coding variants influencing glycemic traits define an effector transcript at the G6PC2-ABCB11 locus.
Mahajan A; Sim X; Ng HJ; Manning A; Rivas MA; Highland HM; Locke AE; Grarup N; Im HK; Cingolani P; Flannick J; Fontanillas P; Fuchsberger C; Gaulton KJ; Teslovich TM; Rayner NW; Robertson NR; Beer NL; Rundle JK; Bork-Jensen J; Ladenvall C; Blancher C; Buck D; Buck G; Burtt NP; Gabriel S; Gjesing AP; Groves CJ; Hollensted M; Huyghe JR; Jackson AU; Jun G; Justesen JM; Mangino M; Murphy J; Neville M; Onofrio R; Small KS; Stringham HM; Syvänen AC; Trakalo J; Abecasis G; Bell GI; Blangero J; Cox NJ; Duggirala R; Hanis CL; Seielstad M; Wilson JG; Christensen C; Brandslund I; Rauramaa R; Surdulescu GL; Doney AS; Lannfelt L; Linneberg A; Isomaa B; Tuomi T; Jørgensen ME; Jørgensen T; Kuusisto J; Uusitupa M; Salomaa V; Spector TD; Morris AD; Palmer CN; Collins FS; Mohlke KL; Bergman RN; Ingelsson E; Lind L; Tuomilehto J; Hansen T; Watanabe RM; Prokopenko I; Dupuis J; Karpe F; Groop L; Laakso M; Pedersen O; Florez JC; Morris AP; Altshuler D; Meigs JB; Boehnke M; McCarthy MI; Lindgren CM; Gloyn AL;
PLoS Genet; 2015 Jan; 11(1):e1004876. PubMed ID: 25625282
[TBL] [Abstract][Full Text] [Related]
5. Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression.
Boortz KA; Syring KE; Pound LD; Wang Y; Oeser JK; O'Brien RM
PLoS One; 2016; 11(9):e0162439. PubMed ID: 27611587
[TBL] [Abstract][Full Text] [Related]
6. A genetic variant of G6PC2 is associated with type 2 diabetes and fasting plasma glucose level in the Chinese population.
Hu C; Zhang R; Wang C; Ma X; Wang C; Fang Q; Bao Y; Xiang K; Jia W
Diabetologia; 2009 Mar; 52(3):451-6. PubMed ID: 19082990
[TBL] [Abstract][Full Text] [Related]
7. Mutations in G6PC2 gene with increased risk for development of type 2 diabetes: Understanding via computational approach.
Udhaya Kumar S; Kamaraj B; Varghese RP; Preethi VA; Bithia R; George Priya Doss C
Adv Protein Chem Struct Biol; 2022; 130():351-373. PubMed ID: 35534112
[TBL] [Abstract][Full Text] [Related]
8. Multiple functional polymorphisms in the G6PC2 gene contribute to the association with higher fasting plasma glucose levels.
Baerenwald DA; Bonnefond A; Bouatia-Naji N; Flemming BP; Umunakwe OC; Oeser JK; Pound LD; Conley NL; Cauchi S; Lobbens S; Eury E; Balkau B; Lantieri O; ; Dadi PK; Jacobson DA; Froguel P; O'Brien RM
Diabetologia; 2013 Jun; 56(6):1306-16. PubMed ID: 23508304
[TBL] [Abstract][Full Text] [Related]
9. Nonsynonymous single-nucleotide polymorphisms in the G6PC2 gene affect protein expression, enzyme activity, and fasting blood glucose.
Overway EM; Bosma KJ; Claxton DP; Oeser JK; Singh K; Breidenbach LB; Mchaourab HS; Davis LK; O'Brien RM
J Biol Chem; 2022 Feb; 298(2):101534. PubMed ID: 34954144
[TBL] [Abstract][Full Text] [Related]
10. Additive genetic effect of GCKR, G6PC2, and SLC30A8 variants on fasting glucose levels and risk of type 2 diabetes.
Chen G; Shriner D; Zhang J; Zhou J; Adikaram P; Doumatey AP; Bentley AR; Adeyemo A; Rotimi CN
PLoS One; 2022; 17(6):e0269378. PubMed ID: 35657990
[TBL] [Abstract][Full Text] [Related]
11. Gene-gene interactions lead to higher risk for development of type 2 diabetes in a Chinese Han population: a prospective nested case-control study.
Zhou W; Li Y; Zhang L; Shi Y; Wang C; Zhang D; Liu X; Mao Z; Li L
Lipids Health Dis; 2018 Jul; 17(1):179. PubMed ID: 30055620
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic islet beta cell-specific deletion of G6pc2 reduces fasting blood glucose.
Bosma KJ; Rahim M; Singh K; Goleva SB; Wall ML; Xia J; Syring KE; Oeser JK; Poffenberger G; McGuinness OP; Means AL; Powers AC; Li WH; Davis LK; Young JD; O'Brien RM
J Mol Endocrinol; 2020 May; 64(4):235-248. PubMed ID: 32213654
[TBL] [Abstract][Full Text] [Related]
13. Multi-omics analysis identifies CpGs near G6PC2 mediating the effects of genetic variants on fasting glucose.
Chung RH; Chiu YF; Wang WC; Hwu CM; Hung YJ; Lee IT; Chuang LM; Quertermous T; Rotter JI; Chen YI; Chang IS; Hsiung CA
Diabetologia; 2021 Jul; 64(7):1613-1625. PubMed ID: 33842983
[TBL] [Abstract][Full Text] [Related]
14. Biochemical and metabolic characterization of a G6PC2 inhibitor.
Hawes EM; Rahim M; Haratipour Z; Orun AR; O'Rourke ML; Oeser JK; Kim K; Claxton DP; Blind RD; Young JD; O'Brien RM
Biochimie; 2024 Jul; 222():109-122. PubMed ID: 38431189
[TBL] [Abstract][Full Text] [Related]
15. Multiple roles of glucose-6-phosphatases in pathophysiology: state of the art and future trends.
Marcolongo P; Fulceri R; Gamberucci A; Czegle I; Banhegyi G; Benedetti A
Biochim Biophys Acta; 2013 Mar; 1830(3):2608-18. PubMed ID: 23266497
[TBL] [Abstract][Full Text] [Related]
16. Genetic and functional assessment of the role of the rs13431652-A and rs573225-A alleles in the G6PC2 promoter that are strongly associated with elevated fasting glucose levels.
Bouatia-Naji N; Bonnefond A; Baerenwald DA; Marchand M; Bugliani M; Marchetti P; Pattou F; Printz RL; Flemming BP; Umunakwe OC; Conley NL; Vaxillaire M; Lantieri O; Balkau B; Marre M; Lévy-Marchal C; Elliott P; Jarvelin MR; Meyre D; Dina C; Oeser JK; Froguel P; O'Brien RM
Diabetes; 2010 Oct; 59(10):2662-71. PubMed ID: 20622168
[TBL] [Abstract][Full Text] [Related]
17. Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes.
Al-Daghri NM; Cagliani R; Forni D; Alokail MS; Pozzoli U; Alkharfy KM; Sabico S; Clerici M; Sironi M
BMC Med; 2012 Nov; 10():140. PubMed ID: 23153210
[TBL] [Abstract][Full Text] [Related]
18. Evolutionary history of glucose-6-phosphatase encoding genes in vertebrate lineages: towards a better understanding of the functions of multiple duplicates.
Marandel L; Panserat S; Plagnes-Juan E; Arbenoits E; Soengas JL; Bobe J
BMC Genomics; 2017 May; 18(1):342. PubMed ID: 28464795
[TBL] [Abstract][Full Text] [Related]
19. Additive effects of genetic variation in GCK and G6PC2 on insulin secretion and fasting glucose.
Li X; Shu YH; Xiang AH; Trigo E; Kuusisto J; Hartiala J; Swift AJ; Kawakubo M; Stringham HM; Bonnycastle LL; Lawrence JM; Laakso M; Allayee H; Buchanan TA; Watanabe RM
Diabetes; 2009 Dec; 58(12):2946-53. PubMed ID: 19741163
[TBL] [Abstract][Full Text] [Related]
20. G6PC2 Modulates the Effects of Dexamethasone on Fasting Blood Glucose and Glucose Tolerance.
Boortz KA; Syring KE; Lee RA; Dai C; Oeser JK; McGuinness OP; Wang JC; O'Brien RM
Endocrinology; 2016 Nov; 157(11):4133-4145. PubMed ID: 27653037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
